(From left) TMC Life Sciences Bhd commercial group senior director Tan Kean Hin, Dr Chong, Inti Labs global business development director Tiffany Wang, Lakshmi, Dr Ling, TMC Fertility and Women's Specialist Centre medical director, consultant obstetrician, gynaecologist and fertility specialist Dr Navdeep Singh and consultant obstetrician, gynaecologist and fertility specialist Prof Dr Prasanna Supramaniam at the announcement of the strategic partnership between both parties in Kuala Lumpur.
KUALA LUMPUR: TMC Fertility has announced a strategic partnership with Inti Labs, pioneers of the non-invasive ORA endometrial receptivity test.
This collaboration is set to transform fertility treatment in Malaysia, significantly boosting IVF success rates and offering patients a more personalised and effective path to parenthood.
The ORA test, developed by Inti Labs, is a cutting-edge advancement in fertility care. This non-invasive genetic test determines the optimal window for embryo transfer, maximising the chances of successful implantation and pregnancy.
Unlike traditional methods that require invasive endometrial biopsies, the ORA test only requires a simple blood sample, providing patients with a comfortable and highly accurate alternative. By integrating the ORA test into its treatment protocols, TMC Fertility continues its commitment to delivering the highest standard of fertility care.
“We are excited to partner with TMC Fertility, a leader in reproductive medicine,” said Inti Labs chief executive officer Eric Pok Yang.
“Our ORA test has the potential to revolutionise fertility outcomes, especially for patients facing complex fertility challenges. We look forward to seeing the transformative impact this collaboration will have on TMC Fertility’s patients.”
TMC Fertility chief executive officer Lakshmi Menon said, “Partnering with Inti Labs to introduce the ORA test represents a pivotal milestone in our mission to provide cutting-edge, personalised fertility treatments.
“This innovative test allows us to tailor our approach for each woman, enhancing their chances for a successful pregnancy. After 30 years of delivering advanced fertility solutions, we are thrilled to offer this new level of care to our patients.”
TMC Fertility consultant obstetrician and gynaecologist and fertility specialists Dr Chong Kuoh Ren and Dr Liza Ling Ping shared, “Integrating the ORA test into our IVF treatments is a major step forward in personalised reproductive care.
“This collaboration with Inti Labs enables us to deliver the most advanced fertility solutions available, improving the precision and effectiveness of our treatments and increasing our patients’ chances of success.”
This partnership underscores a shared dedication to innovation and excellence in fertility care. Patients at TMC Fertility will now benefit from the enhanced precision and individualised care that the ORA test provides, ensuring the best possible outcomes in their fertility journey.
For more information on TMC Fertility and the ORA endometrial receptivity test, visit TMC Fertility and Inti Labs.
